Bridgepoint Considering £550m Bid for London-Listed Advanced Medical Solutions Group
Bridgepoint is exploring a takeover bid for Advanced Medical Solutions Group (AMS), a surgical products maker listed on London's AIM market.
The potential offer is valued at around £550 million to £600 million, which translates to approximately 270p to 280p per AMS share. This would represent a premium of over 30% compared to AMS's current share price of about 208.5p.
It remains unclear whether Bridgepoint has formally approached AMS's board regarding this bid.
Previous interest in AMS included Montagu Private Equity, which withdrew from the process, and Inflexion, which studied a potential offer last year.
AMS is known for manufacturing brands such as LiquiBand and Resorba and currently has a market capitalisation around £455 million.
In its interim results released in September, AMS reported a 49% increase in pre-tax profit.
Both Bridgepoint and AMS declined to comment on the potential takeover bid.
